Skip to main content
Displaying 1 - 12 of 12
Display:
12
24
48
Liver Tumours
AstraZeneca: The evolving treatment landscape of advanced hepatobiliary cancers: expert insights and clinical case discussions...
Webcasts
View
Liver Tumours
Plenary: The expansion of immunotherapy-based combinations in HCC: unmet needs and scientific rationale
Webcasts
View
Liver Tumours
Panel discussion: Multidisciplinary management of patients across the HCC continuum: clinical perspectives and the evolution o...
Webcasts
View
Liver Tumours
Audience Q&A
Webcasts
View
Liver Tumours
Welcome and introductions
Webcasts
View
Liver Tumours
AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection (Complete Sess...
Webcasts
View
Liver Tumours
Panel discussion: Management of patients with HCC in the evolving landscape
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Q/A
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and Introduction to the Event and Keynote Speakers
Webcasts
View
Metabolism, Alcohol & Toxicity
System-based solutions for NAFLD in the UK
Webcasts
View
Metabolism, Alcohol & Toxicity
Current landscape of Non-invasive technologies and the Role of LiverMultiScan Quantitative Multiparametric MRI for Patient Ris...
Webcasts
View
Metabolism, Alcohol & Toxicity
Upcoming NASH Therapeutics; The Need for Non-Invasive Technologies
Webcasts
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy